BNP PARIBAS FINANCIAL MARKETS - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$114,938,000
-89.9%
19,061
-94.0%
0.00%
-100.0%
Q3 2019$1,143,634,000
+2262.7%
317,676
+1658.9%
0.00%
Q2 2019$48,403,000
-48.0%
18,061
-42.6%
0.00%
Q1 2019$93,074,000
+1825.4%
31,444
+934.3%
0.00%
Q4 2018$4,834,000
-83.0%
3,040
-60.6%
0.00%
Q3 2018$28,417,000
+40.9%
7,722
+8.3%
0.00%
Q2 2018$20,169,000
-82.3%
7,127
-76.8%
0.00%
Q1 2018$113,930,000
+53.2%
30,709
+18.9%
0.00%
Q4 2017$74,379,000
+32.3%
25,826
+106.3%
0.00%
Q3 2017$56,219,000
-25.5%
12,521
-23.8%
0.00%
Q2 2017$75,464,000
+773.5%
16,441
+701.2%
0.00%
Q1 2017$8,639,000
-74.3%
2,052
-74.8%
0.00%
Q4 2016$33,635,000
-57.2%
8,144
-16.0%
0.00%
Q3 2016$78,505,000
+121.0%
9,692
+112.8%
0.00%
Q2 2016$35,529,000
-87.0%
4,555
-82.0%
0.00%
-100.0%
Q4 2015$273,246,000
-10.8%
25,324
-42.8%
0.00%0.0%
Q3 2015$306,161,000
+74.7%
44,307
+124.0%
0.00%
Q2 2015$175,251,000
+40.0%
19,780
+55.8%
0.00%
Q1 2015$125,143,000
+104.3%
12,692
+153.8%
0.00%
Q4 2014$61,250,000
-66.3%
5,000
-72.5%
0.00%
Q3 2014$181,676,000
+17.5%
18,204
-10.9%
0.00%
Q2 2014$154,595,000
+3618.9%
20,422
+1531.2%
0.00%
Q4 2013$4,157,000
-94.8%
1,252
-95.2%
0.00%
Q3 2013$79,378,000
-72.6%
26,284
-25.9%
0.00%
Q2 2013$289,965,00035,4480.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders